Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer Novel immunotherapy technology demonstrating ...
Explore the evolving landscape of male contraception, including novel nonhormonal pills and injectable hydrogels in clinical ...
CS2009 was designed to restore T-cell effector function, remodel the tumor microenvironment (TME), and enhance T-cell priming via simultaneous targeting of PD-1, VEGF, and CTLA-4, aiming to generate ...
Dental Piezoelectric Ultrasonic Unit Market is set to reach USD 265.1 million by 2026-end and grow at a CAGR of 5.0% between 2026-2036 ...
Read five key learnings from the Frost & Sullivan 2025 Frost Radar™ for CSPM to learn how CSPM is evolving from point-in-time ...
The M-ELV BattBank is intended for industrial and commercial applications. It is scalable up to 112.56 kWh per cluster.
This joint-specific response pattern was consistent across all advanced treatment modalities, including abatacept, interleukin-6 receptor inhibitors, Janus kinase inhibitors, rituximab and TNFi.
The development of the 6G standard is entering a more concrete phase. At the June 2026 3GPP RAN Plenary in Singapore, the industry advanced several key areas under study and finalized the timeline for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results